A protective polydopamine (PDA) coating is applied to core-shell microcapsule surfaces by the polymerization of dopamine monomers. A neutral aqueous solution and the addition of an oxidant (i.e., ammonium persulfate) are crucial for microcapsule survival and the initiation of PDA polymerization, respectively. The resulting PDA coating is a dense and uniform layer approximately 50 nm thick. The PDA protective coating significantly increases capsule stability at an elevated temperature (180 °C) and in a variety of organic solvents and acidic/basic solutions that otherwise lead to deflation and loss of the core content of uncoated microcapsules.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: